ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Columbus, OH

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Columbus, OH, USA:

Evaluation of the RD-X19 Treatment Device in Individuals With Mild COVID-19

stratified, pivotal efficacy and safety study of the EmitBio RD-X19 treatment device in Individuals 40 Years of age and older with Mild COVID...

Enrolling
COVID-19
Device: RD-X19
Device: Sham
EmitBio

Columbus, Ohio, United States and 47 other locations

Study of LAU-7b for the Treatment of COVID-19 Disease in Adults (RESOLUTION)

A randomized, double-blind, placebo-controlled Phase 2/3 Study of LAU-7b against confirmed COVID-19 Disease in hospitalized patient...

Active, not recruiting
COVID-19 Disease
Drug: Placebo oral capsule
Drug: LAU-7b

Phase 2, Phase 3

Laurent Pharmaceuticals

Columbus, Ohio, United States and 28 other locations

A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults

The purpose of this clinical trial is to see if combining a licensed COVID-19 vaccine and a licensed influenza vaccine into a singl-...

Active, not recruiting
COVID-19
Influenza, Human
Other: Normal saline placebo
Biological: BNT162b2 (Omi XBB.1.5)

Phase 2

Pfizer
Pfizer

Columbus, Ohio, United States and 29 other locations

Study to Evaluate the Efficacy and Safety of Leronlimab for Patients With Severe or Critical Coronavirus Disease 2019 (COVID-19)

is to assess the safety and efficacy of leronlimab (PRO 140) administered as weekly subcutaneous injection in subjects with severe or critical COVID...

Active, not recruiting
Coronavirus Disease 2019
Drug: Leronlimab (700mg)
Drug: Placebos

Phase 2

CytoDyn

Columbus, Ohio, United States and 17 other locations

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

The purpose of this study is to understand the safety and effects of a combined influenza and COVID-19 vaccine. This combined vacci-...

Enrolling
COVID-19
Influenza
Biological: Influenza and COVID-19 Combination B
Biological: Influenza and COVID-19 Combination A

Phase 3

BioNTech
BioNTech

Columbus, Ohio, United States and 158 other locations

Study of Monovalent and Bivalent Recombinant Protein Vaccines Against COVID-19 in Adults 18 Years of Age and Older (VAT00008)

The purpose of this Phase III study is to assess the efficacy, safety, and immunogenicity of two CoV2 preS dTM-AS03 vaccines (monovalent and bivalent...

Active, not recruiting
COVID-19
Biological: Placebo
Biological: SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent D614)(primary series)& SARS-CoV-2 adjuvanted recombinant protein vaccine(monovalent B.1.351)(booster dose)>=4 months after last vaccination

Phase 3

Sanofi
Sanofi

Columbus, Ohio, United States and 93 other locations

A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children

studies or substudies based on age group and prior history of COVID-19 vaccinations. All participants in each of the 5 sub-studies ...

Enrolling
COVID-19
SARS-CoV-2 Virus
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 3 microgram dose
Biological: Variant-adapted BNT162b2 (Omicron XBB.1.5) 10 microgram dose

Phase 2, Phase 3

BioNTech
BioNTech

Columbus, Ohio, United States and 114 other locations

Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia (PREVENT)

side effects. However, it was an expensive treatment and was eventually replaced with less expensive treatment options like penicillin.The COVID...

Active, not recruiting
Covid-19
Sars-CoV2
Radiation: High dose radiation 100 cGy
Radiation: Low dose radiation 35 cGy

Phase 2

The Ohio State University
The Ohio State University

Columbus, Ohio, United States and 6 other locations

Study of a Recombinant Coronavirus-Like Particle COVID-19 Vaccine in Adults

This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...

Active, not recruiting
SARS-CoV-2 Infection
Drug: Intramuscular injection
Biological: Intramuscular vaccine

Phase 2, Phase 3

Medicago

Columbus, Ohio, United States and 90 other locations

A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19 (SCORPIO-HR)

The main aim of this study is to evaluate the efficacy of S-217622 versus placebo among outpatient adults with mild and moderate COVID-19...

Active, not recruiting
SARS-CoV-2 Infection
Drug: S-217622
Drug: Placebo

Phase 3

Shionogi
Shionogi

Columbus, Ohio, United States and 188 other locations

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems